{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:06:43Z","timestamp":1793387203959,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.gastha.2023.10.008","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T05:14:51Z","timestamp":1698124491000},"page":"139-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus"],"prefix":"10.1016","volume":"3","author":[{"given":"Ankoor","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Dossaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Roma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni-Marie","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos D.","family":"Minacapelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4105-5783","authenticated-orcid":false,"given":"Vinod","family":"Rustgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10049","key":"10.1016\/j.gastha.2023.10.008_bib1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.gastha.2023.10.008_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.gastha.2023.10.008_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261878","article-title":"Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection","volume":"16","author":"Suzuki","year":"2021","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.gastha.2023.10.008_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1377\/hlthaff.2018.0035","article-title":"Population health and economic impacts of reaching chronic hepatitis B diagnosis and treatment targets in the US","volume":"37","author":"Toy","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"1, Supplement","key":"10.1016\/j.gastha.2023.10.008_bib6","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jhep.2015.01.018","article-title":"Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs","volume":"62","author":"Locarnini","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"9859","key":"10.1016\/j.gastha.2023.10.008_bib7","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.21037\/hbsn.2019.02.09","article-title":"Current perspectives into the evaluation and management of hepatitis B: a review","volume":"8","author":"Manne","year":"2019","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib11","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","article-title":"High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load","volume":"142","author":"Tseng","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib12","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1053\/j.gastro.2011.06.036","article-title":"Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma","volume":"141","author":"Chen","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for hepatitis B virus infection: CDC recommendations - United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib14","doi-asserted-by":"crossref","first-page":"a021410","DOI":"10.1101\/cshperspect.a021410","article-title":"Hepatitis B virus epidemiology","volume":"5","author":"MacLachlan","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.33073\/pjm-2020-044","article-title":"Hepatitis B virus: from diagnosis to treatment","volume":"69","author":"Guvenir","year":"2020","journal-title":"Pol J Microbiol"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2015.04.026","article-title":"Immigration and viral hepatitis","volume":"63","author":"Sharma","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"24","key":"10.1016\/j.gastha.2023.10.008_bib17","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.3748\/wjg.v20.i24.7665","article-title":"Hepatitis B virus lineages in mammalian hosts: potential for bidirectional cross-species transmission","volume":"20","author":"Bonvicino","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gastha.2023.10.008_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10030580","article-title":"Special issue: \"updates on HBV infection\"","volume":"10","author":"Chemin","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.gastha.2023.10.008_bib19","series-title":"Hepatitis B virus in human diseases","author":"Liaw","year":"2015"},{"key":"10.1016\/j.gastha.2023.10.008_bib20","series-title":"Global epidemiology of hepatitis B virus infection. Hepatitis B virus in human diseases","first-page":"187","author":"Lavanchy","year":"2016"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5005\/jp-journals-10018-1292","article-title":"Hepatocellular carcinoma in Asia: a challenging situation","volume":"9","author":"Jafri","year":"2019","journal-title":"Euroasian J Hepatogastroenterol"},{"issue":"47","key":"10.1016\/j.gastha.2023.10.008_bib22","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-14-7","article-title":"Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986\u201390) and in the nationwide immunisation program","volume":"14","author":"Peto","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"9959","key":"10.1016\/j.gastha.2023.10.008_bib24","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib25","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/microorganisms11051140","article-title":"Vertical transmission of hepatitis B virus-an update","volume":"11","author":"di Filippo Villa","year":"2023","journal-title":"Microorganisms"},{"issue":"9","key":"10.1016\/j.gastha.2023.10.008_bib26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Sheena","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gastha.2023.10.008_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.gaceta.2014.05.007","article-title":"Hepatitis B virus infection and vaccine-induced immunity in Madrid (Spain)","volume":"28","author":"Pedraza-Flechas","year":"2014","journal-title":"Gac Sanit"},{"issue":"24","key":"10.1016\/j.gastha.2023.10.008_bib28","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.3748\/wjg.v20.i24.7635","article-title":"Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy","volume":"20","author":"Sagnelli","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"9791","key":"10.1016\/j.gastha.2023.10.008_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.24804","article-title":"Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin","volume":"56","author":"Kowdley","year":"2012","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.gastha.2023.10.008_bib31","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1158\/1055-9965.EPI-14-0491","article-title":"Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: results from a large, community-based screening, evaluation, and treatment program","volume":"23","author":"Pollack","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40249-016-0228-4","article-title":"Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features","volume":"6","author":"Coppola","year":"2017","journal-title":"Infect Dis Poverty"},{"issue":"35","key":"10.1016\/j.gastha.2023.10.008_bib33","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2015.20.35.30009","article-title":"Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in Southern Italy, January 2012 to June 2013","volume":"20","author":"Coppola","year":"2015","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib34","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00103-016-2333-8","article-title":"[Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany]","volume":"59","author":"Hampel","year":"2016","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/hep.31782","article-title":"An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States","volume":"74","author":"Wong","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gastha.2023.10.008_bib38","doi-asserted-by":"crossref","first-page":"ofaa190","DOI":"10.1093\/ofid\/ofaa190","article-title":"Acute hepatitis B surge: opioid epidemic implication and management challenges","volume":"7","author":"Johansson","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.gastha.2023.10.008_bib39","doi-asserted-by":"crossref","first-page":"a024935","DOI":"10.1101\/cshperspect.a024935","article-title":"Viral hepatitis B: clinical and epidemiological characteristics","volume":"4","author":"Burns","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cld.732","article-title":"Epidemiology of hepatitis B virus infection in the United States","volume":"12","author":"Hyun Kim","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"3","key":"10.1016\/j.gastha.2023.10.008_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15585\/mmwr.mm6503a2","article-title":"Increases in acute hepatitis B virus infections - Kentucky, Tennessee, and West Virginia, 2006-2013","volume":"65","author":"Harris","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/cid\/civ332","article-title":"Epidemiology of acute hepatitis B in the United States from population-based surveillance, 2006-2011","volume":"61","author":"Iqbal","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gastha.2023.10.008_bib43","series-title":"Epidemiology and prevention of vaccine-preventable diseases","year":"2021"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.30831","article-title":"Chronic hepatitis B prevalence among foreign-born and U.S.-Born adults in the United States, 1999-2016","volume":"71","author":"Le","year":"2020","journal-title":"Hepatology"},{"issue":"Rr-8","key":"10.1016\/j.gastha.2023.10.008_bib45","first-page":"1","article-title":"Recommendations for identification and public health management of persons with chronic hepatitis B virus infection","volume":"57","author":"Weinbaum","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.gastha.2023.10.008_bib46","series-title":"Hepatitis and liver cancer: a national strategy for prevention and control of Hepatitis B and C","article-title":"Institute of medicine committee on the P, control of viral hepatitis I","year":"2010"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib47","first-page":"322","article-title":"Hepatitis B status of Hmong patients","volume":"10","author":"Gjerdingen","year":"1997","journal-title":"J\u00a0Am Board Fam Pract"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215011","article-title":"Perinatal hepatitis B virus transmission in Lao PDR: a prospective cohort study","volume":"14","author":"Latthaphasavang","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00046-19","article-title":"Hepatitis B virus: advances in prevention, diagnosis, and therapy","volume":"33","author":"Nguyen","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.gastha.2023.10.008_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12072-021-10285-5","article-title":"Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy","volume":"16","author":"Kumar","year":"2022","journal-title":"Hepatol Int"},{"issue":"8","key":"10.1016\/j.gastha.2023.10.008_bib52","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.cgh.2021.07.036","article-title":"Treatment algorithm for managing chronic hepatitis B virus infection in the United States: 2021 update","volume":"20","author":"Martin","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib53","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cld.2016.06.006","article-title":"Epidemiology of hepatitis B virus infection and impact of vaccination on disease","volume":"20","author":"Nelson","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"50","key":"10.1016\/j.gastha.2023.10.008_bib54","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027941","article-title":"Distribution of hepatitis B virus genotypes and subgenotypes: a meta-analysis","volume":"100","author":"Liu","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.gastha.2023.10.008_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bpg.2017.04.010","article-title":"Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants","volume":"31","author":"Lin","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib56","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4254\/wjh.v14.i4.708","article-title":"Review on hepatitis B virus precore\/core promoter mutations and their correlation with genotypes and liver disease severity","volume":"14","author":"Kumar","year":"2022","journal-title":"World J Hepatol"},{"issue":"9","key":"10.1016\/j.gastha.2023.10.008_bib57","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.3390\/biomedicines10092210","article-title":"Hepatitis B x (HBx) as a component of a functional cure for chronic hepatitis B","volume":"10","author":"Feitelson","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12664-019-00995-y","article-title":"Hepatitis B genotyping: the utility for the clinicians","volume":"39","author":"Fletcher","year":"2020","journal-title":"Indian J Gastroenterol"},{"issue":"20","key":"10.1016\/j.gastha.2023.10.008_bib59","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1128\/JVI.00462-09","article-title":"A\u00a0genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J","volume":"83","author":"Tatematsu","year":"2009","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11894-011-0233-5","article-title":"Is there any value to hepatitis B virus genotype analysis?","volume":"14","author":"Tanwar","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib61","doi-asserted-by":"crossref","first-page":"a021436","DOI":"10.1101\/cshperspect.a021436","article-title":"Hepatitis B virus genotypes and variants","volume":"5","author":"Lin","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48304-z","article-title":"High possibility of hepatocarcinogenesis in HBV genotype C1 infected Cambodians is indicated by 340 HBV C1 full-genomes analysis from GenBank","volume":"9","author":"Chuon","year":"2019","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.gastha.2023.10.008_bib63","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.3748\/wjg.v20.i18.5427","article-title":"Hepatitis B virus genotypes: global distribution and clinical importance","volume":"20","author":"Sunbul","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261721","article-title":"Genetic diversity in enhancer II region of HBV genotype D and its association with advanced liver diseases","volume":"17","author":"Khan","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/hep4.1460","article-title":"Hepatitis B and pregnancy: virologic and immunologic characteristics","volume":"4","author":"Joshi","year":"2020","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.gastha.2023.10.008_bib66","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","article-title":"How viral genetic variants and genotypes influence disease and treatment outcome of chronic Hepatitis B. Time for an individualised approach?","volume":"67","author":"Rajoriya","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.gastha.2023.10.008_bib67","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12072-017-9829-7","article-title":"Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread","volume":"11","author":"Karayiannis","year":"2017","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib68","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.tim.2018.01.009","article-title":"Hepatitis B virus","volume":"26","author":"Shih","year":"2018","journal-title":"Trends Microbiol"},{"issue":"10381","key":"10.1016\/j.gastha.2023.10.008_bib69","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib70","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/v14040657","article-title":"HBsAg loss as a treatment endpoint for chronic HBV infection: HBV cure","volume":"14","author":"Moini","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03501-22","article-title":"Characterization of intracellular precore-derived proteins and their functions in hepatitis B virus-infected human hepatocytes","volume":"14","author":"Hong","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.gastha.2023.10.008_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.02521","article-title":"Immunomodulatory function of HBeAg related to short-sighted evolution, transmissibility, and clinical manifestation of hepatitis B virus","volume":"9","author":"Kramvis","year":"2018","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.gastha.2023.10.008_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/v14081691","article-title":"HBeAg-Negative\/Anti-HBe-Positive chronic hepatitis B: a 40-year-old history","volume":"14","author":"Bonino","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.gastha.2023.10.008_bib75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0168-8278(03)00319-2","article-title":"Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview","volume":"39","author":"Bonino","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/genes10050357","article-title":"The role of hepatitis B core-related antigen","volume":"10","author":"Inoue","year":"2019","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/apt.14376","article-title":"Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection","volume":"47","author":"Mak","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib78","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cld.893","article-title":"CON: all patients with immune-tolerated hepatitis B virus do not need to Be treated","volume":"15","author":"Attar","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"10","key":"10.1016\/j.gastha.2023.10.008_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/v14102275","article-title":"Innate immunity, inflammation, and intervention in HBV infection","volume":"14","author":"Yang","year":"2022","journal-title":"Viruses"},{"issue":"19","key":"10.1016\/j.gastha.2023.10.008_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910462","article-title":"Toll-like receptor response to hepatitis B virus infection and potential of TLR agonists as immunomodulators for treating chronic hepatitis B: an overview","volume":"22","author":"Kayesh","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib81","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1203\/00006450-199101000-00002","article-title":"Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to Hepatitis B e Antigen","volume":"29","author":"Terazawa","year":"1991","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib82","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cgh.2007.01.005","article-title":"Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome","volume":"5","author":"Andreani","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib83","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.21724","article-title":"Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase","volume":"46","author":"Hui","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib84","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","article-title":"Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT","volume":"134","author":"Kumar","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2023.10.008_bib85","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1053\/j.gastro.2008.09.052","article-title":"Should liver biopsies be performed on all hepatitis B carriers","volume":"135","author":"Degertekin","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib87","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010500","article-title":"Hepatocellular carcinoma in chronic viral hepatitis: where do we stand?","volume":"23","author":"Russo","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib89","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/gutjnl-2017-314904","article-title":"High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B","volume":"67","author":"Kim","year":"2018","journal-title":"Gut"},{"issue":"S1","key":"10.1016\/j.gastha.2023.10.008_bib90","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/liv.12996","article-title":"HBV: do I treat my immunotolerant patients?","volume":"36","author":"Vlachogiannakos","year":"2016","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib91","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.gastha.2022.10.004","article-title":"It is time for a simplified approach to hepatitis B elimination","volume":"2","author":"Dieterich","year":"2023","journal-title":"Gastro Hep Adv"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib92","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/s41598-019-39043-2","article-title":"Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.gastha.2023.10.008_bib93","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/MEG.0000000000001345","article-title":"Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: an open-label, randomized, controlled study","volume":"31","author":"Wu","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.gastha.2023.10.008_bib94","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection--natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.gastha.2023.10.008_bib95","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/cld.883","article-title":"Reactivation of hepatitis B virus: a review of clinical guidelines","volume":"15","author":"Myint","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gastha.2023.10.008_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/926836","article-title":"HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF-\u03b1) agents for rheumatic and dermatologic conditions: a systematic review and meta-analysis","volume":"2014","author":"Cantini","year":"2014","journal-title":"Int J Rheumatol"},{"issue":"5","key":"10.1016\/j.gastha.2023.10.008_bib97","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/acr.23346","article-title":"Risk of hepatitis B virus reactivation in patients with inflammatory arthritis receiving disease-modifying antirheumatic drugs: a systematic review and meta-analysis","volume":"70","author":"Lin","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib98","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hep.27716","article-title":"Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection","volume":"62","author":"Barone","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib99","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/1756-185X.14034","article-title":"Risk of hepatitis B reactivation in patients receiving anti-tumor necrosis factor-\u03b1 therapy","volume":"24","author":"Fidan","year":"2021","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"10.1016\/j.gastha.2023.10.008_bib100","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1440-1843.2010.01798.x","article-title":"Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids","volume":"15","author":"Kim","year":"2010","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib101","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Reddy","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gastha.2023.10.008_bib102","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2019.08.023","article-title":"Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure","volume":"72","author":"Wong","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.gastha.2023.10.008_bib103","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s11606-022-07806-9","article-title":"Prevention of hepatitis B reactivation in patients receiving immunosuppressive therapy: a case series and appraisal of society guidelines","volume":"38","author":"Etienne","year":"2023","journal-title":"J\u00a0Gen Intern Med"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277257232300167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277257232300167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:35:14Z","timestamp":1757417714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277257232300167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"alternative-id":["S277257232300167X"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2023.10.008","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2023.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}